Research & Treatment News

Similar, But Different – Hepatitis C Co-Infection and Superinfection

Sep 16, 2014

Dependent on the factor of time, simultaneously having more than one hepatitis infection might accelerate liver disease or it could help scientists develop a Hepatitis C vaccine.

Say it Ain’t So…New Hep C Drug to Surpass $84,000

Sep 15, 2014 6 Comments

The new drug from Gilead could reach upwards of $95,000 - $100,000; but learn why Gilead expects savings for some patients in its pricing scheme.

How Quickly Can HCV be Eradicated?

Sep 11, 2014

New findings emerge that shed light on how long patients may need to be treated with telaprevir in order to achieve viral eradication.

EU Approves Drug That Is Up to 100% Effective Against Hep C

Sep 4, 2014 43 Comments

Boasting an excellent safety record and high success rates, daclatasvir is now approved in Europe to treat Hepatitis C.

HCV Drug Update: Daklinza Gets Europe Approval

Sep 3, 2014

Daklinza, a Bristol-Myers Squibb Inc. drug, was approved for the treatment of Hepatitis C in Japan and now in Europe as well.

Having a Beer After SVR

Aug 29, 2014 27 Comments

After surviving the diagnosis, illness and treatment for Hepatitis C, those who are cured of this illness may once again be faced with a decision to drink alcohol.

Incivek (Telaprevir) Will No Longer be Available for Hepatitis C Patients

Aug 15, 2014 3 Comments

Approved by the FDA as a medication for use in combination with peginterferon alfa and ribavirin to treat chronic Hepatitis C genotype 1 - Incivek will no longer be sold since better medications have become available.